Difficulty: Medium
Average Score: 90%
Practice
Daily long-term control therapy is recommended for infants and young children (0-4 years) who had in the previous year
Correct answer
B
Rationale
The correct answer is B) three or more episodes of wheezing that lasted more than 1 day. Daily long-term control therapy is recommended for infants and young children in this age group who have had three or more episodes of wheezing in the previous year. This is based on the guidelines for managing asthma in children, where persistent wheezing indicates the need for long-term control therapy to prevent exacerbations and maintain optimal lung function.
Option A) two or more episodes of wheezing is incorrect because the guideline specifies three or more episodes as the threshold for initiating daily long-term control therapy. Option C) four or more episodes and Option D) five or more episodes exceed the recommended threshold and would lead to unnecessary treatment in children who do not meet the criteria for daily therapy.
Educationally, it is important for pediatric clinical nurse specialists to understand the criteria for initiating long-term control therapy in young children with asthma to provide appropriate and evidence-based care. Recognizing the appropriate indications for treatment can help prevent unnecessary medication use and improve outcomes for pediatric patients with asthma.
Option A) two or more episodes of wheezing is incorrect because the guideline specifies three or more episodes as the threshold for initiating daily long-term control therapy. Option C) four or more episodes and Option D) five or more episodes exceed the recommended threshold and would lead to unnecessary treatment in children who do not meet the criteria for daily therapy.
Educationally, it is important for pediatric clinical nurse specialists to understand the criteria for initiating long-term control therapy in young children with asthma to provide appropriate and evidence-based care. Recognizing the appropriate indications for treatment can help prevent unnecessary medication use and improve outcomes for pediatric patients with asthma.